Cogstate Ltd. announced that George Hunnewell has concluded his role as Chief Operating Officer of Cogstate and President of the company's Clinical Trials division. Cogstate does not plan to replace the COO and President position. Instead, Cogstate CEO Brad O'Connor will return to a more active role in the day-to-day running of Cogstate's core clinical trials business, which is experiencing continued growth in its existing and new market segments.